To assess the safety and efficacy of the SetPoint System for the treatment of adult patients with active, moderate-to-severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to biologic or targeted synthetic Disease-Modifying Anti-Rheumatic Drugs (DMARDs).
Principal Investigator(s)
Award Info
SetPoint Medical